Article
Adeno-Associated Virus (AAV) Versus Immune Response
25 Jan 2019
Abstract excerpt
Decades ago, Friedmann and Roblin postulated several barriers to gene therapy, including tissue targeting, delivery across the blood⁻brain barrier (BBB), and host immune responses. These issues remain pertinent till today. Since then, several advances have been made in elucidating structures of adeno-associated virus (AAV) serotypes, antibody epitopes, and ways to modify antibody-binding sites. AAVs capsid has...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
